We and others have shown that systemic delivery of CTRP9 attenuates myocardial infarct size in WT or diabetic mice after ischemia-reperfusion injury (IRI) (Kambara et al., 2012; Su et al., 2013). Here, C1QTNF9 is linked to myocardial infarction.